Skip to main content
R

Regent Pacific Group Limited — Investor Relations & Filings

Ticker · 575 ISIN · KYG3042R1314 LEI · 549300TF362HOIC4TJ34 HKEX Financial and insurance activities
Filings indexed 1,259 across all filing types
Latest filing 2024-03-25 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 575

About Regent Pacific Group Limited

http://www.regentpac.com

Regent Pacific Group Limited is an investment holding company primarily focused on the healthcare and life sciences sectors globally. The company specializes in growth and value-led investments, particularly targeting late-stage life sciences assets and biopharma companies. Its core strategy involves building a powerful portfolio of investments intended for commercialization, often achieved through out-licensing agreements with strategic pharmaceutical partners. Regent Pacific operates across key markets, including Europe, the United States, and the Asia Pacific region. A significant area of focus is the longevity medicine business, which utilizes advanced AI technology following the acquisition of Deep Longevity Inc., positioning the company as an engine for emerging AI-driven biopharma solutions.

Recent filings

Filing Released Lang Actions
Discloseable Transaction - Disposal of 25% Equity Interest in the Target Company
Regulatory Filings
2024-03-25 English
Date of Board Meeting
Regulatory Filings
2024-03-15 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-03-01 English
Profit Warning
Regulatory Filings
2024-02-20 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2024-02-02 English
Notification Letter to Registered Shareholders and Reply Form - Election of Means of Receipt of Corporate Communications
Regulatory Filings
2024-01-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.